An Intersectional Perspective on Stigma as a Barrier to Effective HIV Self-Management and Treatment for HIV-Infected African American Women by Adams Tufts, Kimberly
Old Dominion University
ODU Digital Commons
Nursing Faculty Publications Nursing
2015
An Intersectional Perspective on Stigma as a Barrier
to Effective HIV Self-Management and Treatment
for HIV-Infected African American Women
Kimberly Adams Tufts
Old Dominion University, ktufts@odu.edu
Follow this and additional works at: https://digitalcommons.odu.edu/nursing_fac_pubs
Part of the Immune System Diseases Commons, and the Public Health and Community Nursing
Commons
This Article is brought to you for free and open access by the Nursing at ODU Digital Commons. It has been accepted for inclusion in Nursing Faculty
Publications by an authorized administrator of ODU Digital Commons. For more information, please contact digitalcommons@odu.edu.
Repository Citation
Adams Tufts, Kimberly, "An Intersectional Perspective on Stigma as a Barrier to Effective HIV Self-Management and Treatment for
HIV-Infected African American Women" (2015). Nursing Faculty Publications. 6.
https://digitalcommons.odu.edu/nursing_fac_pubs/6
Original Publication Citation
Adams Tufts, K. (2015). An intersectional perspective on stigma as a barrier to effective HIV self-management and treatment for HIV-
infected African American women. HSOA Journal of AIDS Clinical Research and STDs (2), 139-150.
Introduction
 African Americans living with HIV are least likely to be enrolled 
in continuous HIV care and treatment or to achieve viral suppres-
sion [1]. African American women, in particular, represent a higher 
proportion of persons living with HIV at all stages of the virus’ pro-
gression from initial infection to death [2]. More specifically, 64% of 
women living with HIV are African American, and the majority of 
HIV-related deaths among women occur among African American 
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women [2,3]. African American women also experience poorer health 
outcomes compared to others living with HIV [1].
 Caiola and associates [4] suggest that intersectionality is a fitting 
framework for analyzing the complex health inequalities that occur 
among various HIV-infected sub-populations. Empirical evidence 
suggests that barriers to HIV self-management and treatment among 
African American women hinge on something more than simple ad-
herence to Antiretroviral Therapy (ART). Consider, for example, that 
the mortality of African American women living with HIV is great-
er than that of White men, after adjusting for the duration of ART 
[3,5]. The foundation for these health inequalities have, at times, been 
framed as something inherent about African American women them-
selves-due to misbehavior and/or lack of judgment [6]. However, oth-
ers have attributed these inequalities to socioenvironmental factors 
including interpersonal stresses and differences in health care quality 
[7-9].
 This article presents an empirically-based argument about stig-
ma as a formidable obstacle to self-management, care and treat-
ment. Intersectionality is presented as a framework for analyzing 
and understanding the multilayered stigmas [10,11] that face Afri-
can American women who live with HIV. The multiplicative nega-
tive effects of these stigmas, especially in terms of impacts on health 
outcomes: diminished perceived quality of life, poorer rates 
of retention in HIV care and treatment, and suboptimal 
self-management of HIV are highlighted. In conclusion, it is assert-
ed that clinical and research interventions designed to increase these 
women’s engagement in HIV care and treatment must explicitly ad-
dress the complexities of stigma.
Stigma
 The term stigma refers to circumstances under which society views 
an individual as somehow tainted due to an attribute possessed by that 
particular individual [12]. Hence, stigma is a social process wherein 
those who are subjected to stigmatization have decreased power in the 
society. Stigma presents in several forms including enacted, perceived, 
internalized, and anticipated. Enacted stigma refers to sanctions 
applied individually or collectively, such as discrimination or bias. 
Perceived stigma results from negative social attitudes that affected 
persons experienced. Self or internalized stigma refers to accepting 
negative attitudes and beliefs, and applying these attitudes and beliefs 
to one’s self. Internalized feelings of shame or guilt characterize this 
form of stigma. Anticipated stigma is an expectation of future stigma-
tizing experiences such as prejudice, discrimination, and stereotyping.
 Socially endorsed stigmas often predetermine which social or 
cultural groups will be stigmatized. Consequently in many societ-
ies; women, those from ethnic minority backgrounds, and those 
with less economic power may experience multiple stigmas which 
are synergistic in nature, i.e., interacting together with each stigma 
contributing to the magnification of potential barriers to optimal 
health outcomes [13]. The theory of intersectionality assumes that 
socially constructed identities such as gender, race and class, interact 
in the context of social and power relations to create a unique health 
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experience. Therefore, intersectionality is a useful framework for ana-
lyzing the syndemic impact of these stigmas on the HIV-infected Af-
rican American woman’s health care experience.
Intersectionality
 The examination of power differentials; relationships between 
dominants and subordinates is at the core of the intersectional 
framework. Intersectionality was not developed to predict actions 
or cognitive processes; rather, it is a framework for analysis [14]. 
Intersectionality puts forth that HIV is often not the sole factor 
that precipitates the stigma experienced by these women; it posits 
that multiple factors precipitate stigmatizing experiences. An in-
tersectional perspective acknowledges that these women’s social 
identities experienced at the individual level (e.g., being female, an 
ethnic minority, and/or of low SES) interlock with oppressive forc-
es at the macro-level of society (i.e., sexism, racismand classism) 
to create social injustices (e.g., health care inequalities). Intersec-
tionality concedes that race and class are gendered thus producing 
compounded inequalities for marginalized groups, such as African 
American women. African American women were, in fact, the origi-
nal focus of intersectionality theory [15].
 The intersectional perspective recognizes that the socially con-
structed identities of these women both contribute to the wom-
an’s formative experiences and influence the sum total of these 
experiences. This framework acknowledges the African Amer-
ican woman’s gender, race, class and disease conditions are not 
mutually exclusive. Instead, these attributes may be a collective 
catalyst for stigma-related experiences that are not generated by posi-
tive HIV serostatus alone; augmenting each other and contributing to 
stigmatizing health care encounters that further marginalize African 
American women living with HIV [6,16].
 Historical notions about the African American woman’s place 
in US society have fueled the social construction of stereotypes. 
Frequently, for example, the media portrays African American wom-
en as being poor, downtrodden, hyper-sexed and as being drug users/
abusers; in a word, they are depicted as dysfunctional [17,18].
 Therefore, in reality, it is quite difficult to detangle the impact of 
one factor from another especially in the context of HIV frequently 
being sexually transmitted and/or due to illicit drug use. However, for 
purposes of clarity these factors will be presented separately to allow 
for a focused analysis of each factor and to illustrate have they may 
interact to further magnify the impact of HIV-related stigma on en-
gagement in HIV care, treatment, and self-management.
Stigma and Gender
 HIV-related stigma cannot be fully explored without taking gen-
der into account. Gender is a social construct that does not refer to 
biological characteristics but rather to culturally determined role 
expectations for how men and women must act in society. In many 
societies, unequal power differentials continue to exist between 
men and women. Thus, gender must be considered when analyzing 
power structure and access to resources in the United States (US), 
where historically and socioculturally women have had lower social 
standing than men [19]. The challenges of power inequalities and 
group subordination within the social construction of gender have 
become increasingly important in the context of HIV transmission 
and engagement in HIV care, and treatment [20,21]. For women, 
HIV-related stigma is frequently layered on top of the stigma and 
discrimination that sexism generates. Notably, gendered experiences 
of daily living and their impact on access to resources, power, and in-
fluence on risk behaviors have been associated with higher risk for 
HIV and less than optimal HIV-related health outcomes for some 
groups including African American women [22].
 Women, experience HIV-related stigma differently and report 
higher levels of HIV-related stigma [23,24]. Women living with HIV 
and their families are more likely to experience discrimination and a 
loss of social support [25-27]. In a study exploring HIV-related stig-
ma and discrimination conducted with 536 people living with HIV 
(67% female) across four sub-Saharan African countries women 
were significantly more likely to report interpersonal discrimination 
[27]. HIV-infected women are often hesitant to disclose their status 
for fear of being labeled promiscuous, a drug user, or simply dirty 
[20,28]. They know that disclosing their medical condition to others 
may jeopardize their personal relationships and economic status [21]. 
Lower rates of disclosure of positive serostatus among women have 
been associated with increased reports of mental health challenges 
[25]. In the case of African American women these challenges may be 
compounded because they may be subject to multiplicative stigmas; 
marginalized not only because they are women but because they are 
persons of color.
Stigma and Race
 Socioenvironmental stresses have been associated with ac-
celerated health deterioration among African American wom-
en when compared to US born Caucasian women. The social 
construction of race and race relations is prominent among the 
hypothesized etiologies for this phenomenon. Race has tradi-
tionally been drawn along the lines of “black and white” in the US 
[29,30] for purposes of establishing and maintaining power dif-
ferentials. Racial discrimination has been associated with higher 
incidences of hypertension [31] and accelerated biological aging 
among African Americans [32] these processes have been conceptual-
ized as “weathering”[9,33].
 Many African American women experience pervasive racism 
throughout the life course [34]. For HIV-infected African Amer-
ican women gender-related stigma and the subsequent negative 
power differentials are often compounded by racial discrimination 
and/or racism. The subjective experience of racism includes subtle 
ideologies such as the concept of “free will,” which implies that Af-
rican American women’s disadvantages are principally their own 
responsibility [35]. “Free will” can be the basis for assuming that Af-
rican American women have contracted HIV due to their own risky 
behaviors [26]. Thus, all forms of racism, including the perpetua-
tion of racially-based stereotypes, can contribute to the level of en-
acted, perceived, internalized and/or anticipated stigma that African 
American women living with HIV experience. Racialized stereotypes 
about African American women abound in pop culture: ranging 
from the bitchy person as depicted on “reality” TV shows to the ti-
tles of popular fiction that target African American readers [18,36]. 
Racialized framing can also prompt healthcare providers to assume 
that risks for medical conditions, such as hypertension-associated re-
nal disease or HIV, are due to African Americans’ biological charac-
teristics, rather than due to socioeconomic and/or structural factors 
[8,31,37,38].
 Such negative racial stereotypes and their deleterious effects 
on African American women’s self-esteem and self-image have 
been associated with enhanced risks for engaging in risky sexual 
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behaviors, remaining in abusive relationships, and contracting HIV 
[39]. The intersectional perspective asserts that when an African 
American woman contracts HIV, negative historical stereotypes are 
augmented by additional stereotypes about promiscuity, drug use, 
lack of capacity for engaging in positive health behaviors (e.g., poor 
potential for adherence), and by the stigma associated with these ste-
reotypes. Socially-constructed, negative images about race and HIV 
may color provider-patient interactions, ultimately limiting the poten-
tial for an effective therapeutic relationship.
Stigma and Class
 Persons living with HIV, who also have lower incomes, have re-
ported higher levels of stigma [40]. This is particularly disconcerting, 
because HIV has been termed a pandemic of the poor [41]. Similar to 
other health inequalities [42], risk and prevalence of HIV have also 
been associated with lower educational attainment and under- or un-
employment-and are, thus, associated with lower Socioeconomic Sta-
tus (SES), where SES is generally an aggregate measure of education, 
income, and occupational status. Nonetheless, SES is often conceptu-
alized as class or social standing, when viewed through a social class 
lens, which emphasizes privilege, power, and control.
 Notably, African American women are most often cared for by 
White health care providers of upper-middle class or upper-class 
standing [43]. In the context of these status inequalities, HIV-in-
fected African American women are frequently assumed to be of a 
lower socioeconomic standing, until they prove otherwise [19,44,45]. 
If a provider possesses implicit biases about persons of lower socio-
economic status, African American women can be presumed to be 
noncompliant, “lost causes”. These presumptions may impact these 
women’s care and treatment [46-48]. In fact, compared to men, 
women are less likely to receive ART [49]. Hence, when one con-
siders the contexts of race and class in addition to gender, African 
American women may be even less likely to receive ART in a time-
ly fashion and may be more likely to experience the sequelae of 
inadequate viral suppression such as chronic inflammation [50]. 
Biased perspectives of socioeconomic status can combine with 
HIV-related stigma to create a less therapeutic provider to pa-
tient relationship. This was apparently the case for a group of 
HIV-infected African American women who participated in a quali-
tative study on stigma and HIV. At times these women reportedly felt 
socially shunned and disregarded when accessing healthcare services 
[26].
 Intersectionality concedes that at the point of service, the African 
American woman often faces classism in addition to sexism and rac-
ism. The African American woman of lower socioeconomic means 
is frequently viewed as possessing little privilege or power. She must 
be directed as to how to care for herself and is expected to comply 
with instructions, rather than be free to participate in mutual goal-set-
ting about her own health and self-management of HIV. Additionally, 
if public funds support her HIV care and treatment (i.e., Medicaid, 
Ryan White), she is often viewed as one of the collective “undeserving 
poor”[51]. At times her circumstances including that of being HIV-in-
fected may be considered to be the result of her own individual fail-
ures, rather than of societal or systemic failures.
Stigma and HIV
 Unfortunately, due to the nature of most HIV transmissions, HIV 
is often believed to be contracted as a penalty for misbehavior or lack 
of judgment [52]. Thus, not unlike other stigmas, HIV-related stigma 
is also a sociocultural phenomenon. HIV-related stigma is a prejudice 
that discounts, devalues, and discriminates against persons believed 
to have HIV along with other individuals and/or communities with 
which these persons are presumed to be affiliated [53]. A 2015 synthe-
sis of 55 qualitative studies revealed that people living with HIV com-
monly report that they have encountered stigma in healthcare settings 
[54]. Gagnon’s recent interviews of 21 HIV-infected persons exposed 
that stigmatizing interactions, though episodic in nature, continue to 
persist in health care settings in the form of individual interactions 
and institutional policy [55]. Notably, HIV-related stigma has been as-
sociated with less than optimal HIV-related health outcomes includ-
ing decreased likelihood of initiating HIV care [56], ART non-adher-
ence, CD4 counts less than 200 cells/mm and higher prevalence of 
co-morbidities [57,58].
 Stigma takes several forms for persons living with HIV: enacted, 
perceived, internalized and/or anticipated [52,53,57]. All forms trig-
ger anxiety or fear about other people’s reactions to one’s serostatus. 
Notably, stigmatizing experiences have been shown to be predictors of 
lack of engagement in HIV care and treatment as evidenced by missed 
health care appointments [40]. Different forms of stigma seemingly 
may have diverse influences on health status. Recently, Earnshaw and 
colleagues put forth that specific forms of HIV-related stigma were 
associated with different health behaviors and outcomes. For example, 
internalized stigma was specifically associated with ART non-adher-
ence while enacted and anticipated stigma were linked to the presence 
of co-morbid conditions and lower CD4 counts [57]. Anticipated stig-
ma has also been linked with patterns of HIV disclosure [21].
 Hence, HIV-infected African American women who perceive 
HIV-related stigma in addition to other interlocking forms of stig-
ma, may then experience shame, guilt, and depression, and conclude 
they are unworthy of self-care and good health, resulting less than 
optimal engagement in HIV self-management, care and treatment 
[10,11,23,59,60]. Intersectionality allows that their trepidation about 
the possibility of being discounted, devalued, and discriminated 
against due to being HIV-infected in the context their gender, race 
and class may multiply to present a nearly insurmountable barrier to 
effective HIV self-management and active engagement in treatment 
[27].
Engagement in HIV Care, Treatment and Self-man-
agement
 There is a preponderance of evidence that active self-manage-
ment positively impacts outcomes for persons living with chronic 
diseases. Adherence to prescribed medical regimens and engaging 
in active self-management of HIV are essential to living well with 
HIV. Whatever the source, stigma affects disclosure patterns, health 
outcomes, and quality of life for those living with HIV [43,60-62]. 
Social support has been identified as a facilitator of self-management 
of HIV and significantly associated with positive coping for women 
living with HIV [16,63]. African American women who encoun-
ter and/or anticipate stigma related to HIV, may infer that engaging 
in HIV self-management might disclose their serostatus directly or 
indirectly-thus, jeopardizing their actual or potential social support 
networks.
 This perspective is not without justification, given what is known 
about gender differences and HIV-related stigma. Compared to men, 
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being a woman has been associated with higher levels of stigmatized 
attitudes toward persons living with HIV [64,65] and women most 
often look to other women for social support. It is, therefore, hardly 
surprising that African American women might not present readily 
for HIV care or take ART; they may anticipate that such services will 
impact confidentiality within their communities, resulting in a loss of 
social support from other women. As emphasized earlier, loss of social 
support due to stigma also compromises health outcomes as a result of 
enhanced risk for non-adherence to ART [58] and less than optimal 
self-management [16]. Accordingly, preserving confidentiality and 
neutralizing potentially stigmatizing interactions are foundational to 
HIV care and treatment services and when designing programmatic 
and investigational interventions.
Conclusion
 African American women constitute a specific population who 
carry distinct sociocultural luggage into the realm of HIV care and 
treatment. They have often experienced structural inequalities related 
to gender, race and class. Alas, in the case of the African American 
woman the presence of HIV infection may be spur additional stigma 
that further compounds the stigmas generated by these pre-existing 
factors. Conversely stigma related to HIV infection may be magnified 
in the presence of female gender, black race and lower socioeconomic 
status [10,20].
 Intersectionality helps us to recognize and begin to understand the 
social constructs and power relationships that precipitate stigmas and 
the multiplicative effects of various forms of stigma on these women’s 
view of themselves, their material resources, propensity for engaging 
in HIV self-management, and their perceived access to health care 
services. Yet, HIV-infected African American women do not have to 
be victims of stigma; they can be resilient and resourceful even in the 
face of this virus [26,57]. Health care providers and researchers have a 
responsibility to employ stigma neutral gender-specific and culturally 
relevant interventions that promote resiliency in these women.
 Evidence-based stigma reduction interventions are limited. 
Most interventions teach clinicians about stigma and its affect in-
stead of helping them to effectively address the various underly-
ing sources of their own stigmas and enabling them to build ca-
pacity for assisting persons living with HIV to successfully copy 
with stigmatization [10,66,67]. Interventions designed to assist 
HIV-infected African American women live well with HIV and to 
enhance their health outcomes must strategically minimize the im-
pact of stigma, while incorporating methods for facilitating strong 
social support networks and adaptive coping. Specifically, these in-
terventions must take into account the intersectional perspective; 
accounting for the negative racialized and class-based ideologies, 
images, narratives, and implicit bias [47,48] that color health care 
interactions for African American women living with HIV. Such 
initiatives must recognize that, when these women perceive that 
stigma is at work, they will not be likely to engage fully in their own 
care or be skilled at self-managing their illness. Therefore, it is im-
perative that the design and development of culturally relevant gen-
der-specific stigma reduction strategies be at the forefront of any 
public health efforts to decrease community-specific levels of HIV 
incidence and prevalence not relegated to the bottom of budgetary 
priorities.
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